The Review of Diabetic Studies (RDS) is a very carefully edited journal, with each paper provided with a scientific and linguistic expert throughout the entire reviewing and publication process to serve the author and realize the optimal result for the publication of the paper. The reviewing and proof preparation processes are supervised by the Editor, who personally read and carefully edit any paper published before a final language correction is carried out by a professional, English native-speaking linguist.
The Editors attach importance (1) to the way of presentation of the data and information, which should be substantiated, balanced, and novel, and (2) to the selection of topics to address the most burning questions in diabetes research. As the journal and the publisher are totally dedicated to scientific and charitable interests and are not afflicted with any commercial interests (in contrast to most other journals), the journal's only goal is the progress in science, which is reflected in the carefully editorial work and the huge effort spent by the Editorial Team in order to create excellence and impact-capturing reference in scientific publishing. The Editors wish to increases attention to unresolved issues that are regarded as most important in scientific progress and clinical translation of therapies aimed at both improving diabetes management and an ultimate cure. The RDS Editorial Board comprises a group of leading experts from the different fields of research into diabetes; they are closely collaborating to identify the most relevant topics and to organize Paper Series Projects addressing these topics.
The RDS supports and encourages research in biomedical diabetes-related science including areas such as endocrinology, immunology, epidemiology, genetics, cell-based research, developmental research, bioengineering, and disease management. The journal publishes original manuscripts on laboratory research, clinical and empirical studies, case and conference reports as well as review and theoretical articles and offers an open forum for immediate discussion of recent advancements by letters and comments. Read more
Abbreviation title : Rev Diabet Stud
Frequency : Quarterly
ISSN print edition : 1613-6071
ISSN online edition : 1614-0575
Editor : Demosthenes Panagiotakos, MD, PhD
Hon. Editor : Anders A. Sima, M.D., Ph.D.
The journal supports a fast review process. 95% of all reviews are returned to authors within 3-4 weeks after paper submission.
Statistics about paper acceptance and rejection:
The 2016 rejection rate was: 63.4%
Responsibility for the selection of articles in The RDS remains with the Editorial Board. However, the editors do not assume responsibility for the views and statements expressed by the authors.
The RDS is also available online via DOD (Diabetes Open Directory), a database containing information and publications from diabetes-related biomedical research which is currently in its beta stage.
|Year||Impact Factor (2-yr)*||
Impact Factor (3-yr)*
|Weighted Impact Factor (2-yr)**|